Inhibitor of human plasma kallikrein DX-88 for the treatment of acute attack in a family with hereditary angioedema

被引：0

作者：

Anne, R

Deveras, E

Bracho, F

机构：

[1] Georgetown Univ Hosp, Div Hematol Oncol, Washington, DC 20007 USA

[2] Georgetown Univ Hosp, Div Pediat Hematol Oncol, Washington, DC 20007 USA

来源：

BLOOD | 2004年 / 104卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4109

引用

页码：113B / 114B

页数：2

共 50 条

[1] DX-88 a recombinant inhibitor of human plasma kallikrein. Efficacy and safety in hereditary and acquired angioedema
Cicardi, M
Gonzalez-Quevedo, T
Caballero, T
Bork, K
Williams, A
[J]. MOLECULAR IMMUNOLOGY, 2003, 40 (2-4) : 197 - 198
[2] DX-88 a recombinant inhibitor of human plasma kallikrein. Evalation of efficacy and safety in patients with hereditary angioedema
Williams, T
Cicardi, M
Bork, K
Gonzalez-Quevedo, T
Caballero, T
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 111 (04) : 908 - 908
[3] Anaphylactic reaction and antibodies to DX-88 (kallikrein inhibitor) in a patient with hereditary angioedema
Caballero, T
López-Serrano, C
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : 476 - 477
[4] Anaphylaxis in response to C1 esterase inhibitor in a patient with hereditary Angioedema - Successful treatment with DX-88, a human plasma kallikrein inhibitor
Zingale, Lorenza C.
Zanichelli, Andrea
Deliliers, Daniela Lambertenghi
Cicardi, Marco
[J]. ALLERGY & CLINICAL IMMUNOLOGY INTERNATIONAL-JOURNAL OF THE WORLD ALLERGY ORGANIZATION, 2007, 19 (04): : 159 - 163
[5] Anaphylactic reaction and antibodies to DX-88 (kallikrein inhibitor) in a patient with hereditary angioedema - Reply
Beck, TR
Baird, LG
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : 477 - 477
[6] Ecallantide (DX-88), a plasma kallikrein inhibitor for the treatment of hereditary angioedema and the prevention of blood loss in on-pump cardiothoracic surgery
Lehmann, Andreas
[J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (08) : 1187 - 1199
[7] Resolution of bowel obstruction in a patient with hereditary angioedema treated with DX-88 (Ecallantide1), a potent human plasma kallikrein inhibitor:: A case study
Cicardi, Marco
Zingale, Lorenza C.
Zanichelli, Andrea
[J]. MOLECULAR IMMUNOLOGY, 2007, 44 (1-3) : 160 - 160
[8] Results of a repeat-dosing study of intravenous and subcutaneous administration of ecallantide (DX-88), a recombinant plasma kallikrein inhibitor, in patients with hereditary angioedema.
Lumry, W.
Li, H.
Schneider, L.
Leflein, J.
Craig, T.
Morrison, J.
[J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2007, 98 (01) : A29 - A29
[9] ECALLANTIDE: A PLASMA KALLIKREIN INHIBITOR FOR THE TREATMENT OF ACUTE ATTACKS OF HEREDITARY ANGIOEDEMA
Stolz, L. E.
Horn, P. T.
[J]. DRUGS OF TODAY, 2010, 46 (08) : 547 - 555
[10] DX-88, a novel Kunitz-type inhibitor of human plasma kallikrein with potential therapeutic use.
Mackie, IJ
Lawrie, AS
Purdy, G
Williams, T
Machin, SJ
[J]. BLOOD, 2002, 100 (11) : 88B - 89B

← 1 2 3 4 5 →